Brief Description
RAINIER is a clinical research study for adults with immunoglobulin A nephropathy (IgAN).
Estimated Enrollment
480
Estimated End Date
May 29th, 2026
Trial is for people with
immunoglobulin A nephropathy (IgAN)
Study Goal
This study is measuring the safety and effectiveness of the study drug compared to placebo in participants with IgA nephropathy.
What is involved for the patient?
Study participation is a little longer than 2 years. Study Participants will attend in-person study visits to receive the study ...
About the drug or intervention
The study drug is an injection given once every 4 weeks just under the skin in the arm, thigh, or belly. It might block 2 proteins ...